期刊文献+

血清OPG、hs-CRP与冠心病的相关性 被引量:4

Serum OPG,hs-CRP and coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病(CHD)患者血清骨保护素(OPG)、超敏C反应蛋白(hs-CRP)水平及冠状动脉病变程度的关系。方法选取入住我院心内科的患者,按疾病严重程度分为急性冠脉综合征(ACS)组(n=30例)、稳定型心绞痛(SA)组(n=30例)及对照组(CO)组(n=10例),检测并比较3组患者血清OPG、hs-CRP表达水平的差异。结果 ACS组患者血清OPG及hs-CRP水平明显高于SA组及CO组,SA组血清OPG及hs-CRP水平高于CO组(P<0.01或P<0.05)。血清OPG、hs-CRP含量均随冠脉病变数目的增加而增高,且血清OPG水平与hs-CRP水平呈正相关(P<0.01)。结论冠心病患者血清OPG、hs-CRP水平与冠状动脉病变程度有关,提示OPG系统可能通过干预血管炎症反应而参与了冠状动脉粥样硬化病变进程。 Objective To analyses the relationship between the levels of serum osteoproteger in OPG, hyper sensitive C- reactive protein (hs-CRP) and severity of coronary artery lesions. Methods All of 60 cases of patients with CHD were divid- ed into acute coronary syndrome groups(ACS) and stable angina pectoris groups (SA) according to pathogenetie condition, 10 health human were divided into control groups. The level of OPG and hs-CRP in serum were detected with enzyme linked immunosorbent assay way, and expressive difference were contrast. Results Serum OPG and hs-CRP levels were significantly higher in ACS group than those in SA group and controls group (P〈0.01 or P〈0.05). As the number o f diseased vessels increased, there was a significant increase in serum OPG and hs-CRP levels (P〈0.01). A positive relation was found between OPG levels and hs-CRP (P〈0.01). Conclusion Serum OPG and hs-CRP levels are associated with the stenosis degree of the coronary artery in patients with acute coronary syndrome, suggesting that OPG system may be involved in the progression of coronary atherosclerosis lesions.
出处 《中国现代医生》 2012年第2期16-17,20,共3页 China Modern Doctor
关键词 冠心病 骨保护素(OPG) 超敏C反应蛋白(hs—CRP) 冠脉病变程度 Coronary heart disease Osteoprotegerin Hyper sensitive C-reactive protein Coronary artery disease extension
  • 相关文献

参考文献8

  • 1Gray J E, Luan B. Protective coatings on magnesium and its alloys a critical review [J]. Journal of Alloys and Compounds, 2002,336 (1-2): 88-113
  • 2Pawlek R P, Brown R B. World primary and secondary magnesium review [J]. Light Metal Age, 2001, 59 (8): 50-57
  • 3Mordike B L, Ebert T. Magnesium: properties-applications-potential [J]. Materials Science and Engineering, 2001, A302:37-45
  • 4Lamberigts M, Walmag G, Cotsouradis D, et al. Friction and ductility behaviors of a high strength zinc foundry alloy [J]. AFS Transaction, 1985, 93:569-578
  • 5Haitani T, Tamura Y, Motegi T, et al. Solubility of iron in magnesium and cast structure of Mg-Fe alloy [J]. Material Science Forum, 2003, 419-422:697-702
  • 6Tamura Y, Motegi T, Kono N, et al. Effect of minor elements on grain size of Mg-9% Al alloy [J]. Material Science Forum,2000, 350-351:199-204
  • 7Haitani T, Tamura Y, Yano E, et al. Grain refining mechanism of high purity Mg-9 mass % Al alloy ingot and influence of Fe or Mn addition on cast grain size [J]. Journal of Japan Institute of Light Metals, 2001, 51:403~408
  • 8Lunder O, Aune T K, Nisancioglu K. Effect of Mn additions on the corrosion behavior of mould cast magnesium ASTM AZ91 [J].Corrosion, 1987, 43 (5): 291-295

共引文献1

同被引文献52

  • 1王晓蓉.冠心病患者检测同型半胱氨酸以及超敏C反应蛋白的临床价值[J].环球中医药,2013,6(S1):90-91. 被引量:3
  • 2罗助荣,张克己,林毅,等.ASC廊清OPG、sRANKL与hs-CRP及冠状动脉病变程度的相关性研究[J].临床心缸管病杂志,2011,17(2):499-501.
  • 3Hofbauer LC,Khosla S,Dunstan CR.The roles of steoprotegerin and osteoprotegerin ligand in the paraerineregulation of bone resorption [J]. Journal of Bone and Mineral Research,2008,12(1):211-212.
  • 4Wei G,Yaqi R,Ningfu W,et al. N-terminal prohormone B- type natriuretic peptide and cardiovascular risk in stable coronary artery disease :a meta-analysis of nine prospec- tive studies [J]. Rev C ardiovasc Med,2013,14 (2-4):92- 98.
  • 5Rajabiani A,Mohaghgheghi A,Kamal-Hedayat D,et al. Does serum N-terminal pro-brain natriuretic peptide level predict the severity of angiographic lesions in patients with acute coronary syndrome? [J]. J Tehran Heart Cent, 2013,8 (3) : 152-157.
  • 6Lu YC ,Hsu CC ,Yu TH,et al. Association between visfatin levels and coronary artery disease in patients with chronic kidney disease [J]. Iran J Kidney Dis,2013,7(6):446-452.
  • 7Chen TH, Lin CL, Shih J J, et al. Plasma B-type natriuret- ic peptide in predicting outcomes of eleetive coronary artery bypass surgery [J]. Kaohsiung J Med Sci ,2013,29 (11):650.
  • 8Baha S,Demir M,Demirkol S,et al. Plasma B-type na- triuretic peptide level in patients with coronary artery bypass surgery [J]. Kaohsiung J Med Sci,2013,29 (11): 648-649.
  • 9Giannitsis E,Spanuth E, I-Iorsch A, et al. High-sensitivi- ty cardiac troponin T and N-terminal pro-B-type natri- uretic peptide predict mortality in stable coronary artery disease:results from the Ludwigshafen risk and cardio- vascular health(LURIC)study [J]. Clin Chem Lab Med, 2013,51 (10) :2019-2028.
  • 10李秋生,陈魁.骨保护素系统与动脉硬化性疾病[J].心血管病学进展,2008,29(3):473-477. 被引量:8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部